Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present American Renal Associates Holdings, Inc. (NYSE: ARA).

Full DD Report for ARA

You must become a subscriber to view this report.


Recent News from (NYSE: ARA)

Wired News - Heska Collaborates with MBio Diagnostics for Developing New Products for the Veterinary Market
Stock Monitor: American Renal Associates Holdings Post Earnings Reporting LONDON, UK / ACCESSWIRE / May 17, 2018 / If you want access to our free research report on Heska Corp. (NASDAQ: HSKA ), all you need to do is sign up now by clicking the following link www.active-investors.com/...
Source: ACCESSWIRE IA
Date: May, 17 2018 07:40
Recent Analysis Shows Paycom Software, American Renal Associates, Knowles, Timken, Nevro, and Unisys Market Influences - Renewed Outlook, Key Drivers of Growth
NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Paycom Software, Inc. (NYSE:PAYC), American Renal Associates Holdings, Inc...
Source: GlobeNewswire
Date: May, 15 2018 07:45
American Renal Associates Holdings' (ARA) CEO Joseph Carlucci on Q1 2018 Results - Earnings Call Transcript
American Renal Associates Holdings, Inc. (ARA) Q1 2018 Earnings Conference Call May 09, 2018, 09:00 ET Executives Darren Lehrich - SVP, Strategy & IR Joseph Carlucci - Co-Founder, CEO & Chairman Syed Kamal - Founder, President & Director Don Williamson - EVP & C...
Source: SeekingAlpha
Date: May, 13 2018 00:42
American Renal beats by $0.02, beats on revenue
American Renal (NYSE: ARA ): Q1 EPS of $0.11 beats by $0.02 . More news on: American Renal Associates Holdings, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 08 2018 16:41
American Renal Associates Holdings, Inc. Announces First Quarter 2018 Results
American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading provider of outpatient dialysis services, today announced financial and operating results for the first quarter ended March 31, 2018. Certain metrics, including those expressed on an adjust...
Source: Business Wire
Date: May, 08 2018 16:05
American Renal Associates Holdings, Inc. Announces Upcoming Conference Appearance
American Renal Associates Holdings, Inc. (NYSE: ARA), a leading provider of dialysis services, today announced it will participate at the Bank of America Merrill Lynch 2018 Healthcare Conference in Las Vegas, NV. Joe Carlucci, Chairman and Darren Lehrich, SVP of Strategy & Investor R...
Source: Business Wire
Date: May, 02 2018 16:15
American Renal Associates Holdings, Inc. Announces First Quarter 2018 Earnings Release Date and Conference Call
American Renal Associates Holdings, Inc. (NYSE: ARA), a leading provider of dialysis services, announced today that it will release its first quarter 2018 financial results after the market close on Tuesday, May 8, 2018, to be followed by a conference call on Wednesday, May 9, 2018 at 9:00 a...
Source: Business Wire
Date: April, 24 2018 16:30
American Renal Associates Holdings, Inc. Announces Settlement of Shareholder Derivative Litigation
American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading provider of outpatient dialysis services, is pleased to announce that the Company has received preliminary approval of the settlement of a stockholder derivative action brought by Plaintiff Stephen ...
Source: Business Wire
Date: April, 20 2018 16:30
American Renal Associates +7.9% as it withdraws secondary
American Renal Associates (NYSE: ARA ) has withdrawn a stock offering it announced Monday, due to market conditions. More news on: American Renal Associates Holdings, Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: March, 28 2018 20:31
American Renal Associates Holdings, Inc. Announces Withdrawal of Secondary Public Offering of Common Stock
American Renal Associates Holdings, Inc. (NYSE: ARA) (“ARA” or the “Company”), a provider of outpatient dialysis services, today announced that it has withdrawn the offering of shares of its common stock that was announced on Monday, March 26, 2018. The Company be...
Source: Business Wire
Date: March, 28 2018 18:01

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1815.8215.2115.8215.18110,079
2018-05-1715.8215.2115.8215.18110,079
2017-11-0811.1310.5911.1310.32257,256
2017-11-0711.5211.2211.6411.20129,862
2017-11-0611.4611.5611.7911.46101,596

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-171,6361,64499.5134Short
2018-08-164,9779,59151.8924Short
2018-08-153771,10434.1486Cover
2018-08-142022,7777.2740Cover
2018-08-133049,0883.3451Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ARA.


About American Renal Associates Holdings, Inc. (NYSE: ARA)

Logo for American Renal Associates Holdings, Inc. (NYSE: ARA)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $481,709,080 - 05/11/2018
  • Issue and Outstanding: 32,049,839 - 03/05/2018

 


Recent Filings from (NYSE: ARA)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 28 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: March, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 26 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: March, 19 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 16 2018

 

 


Daily Technical Chart for (NYSE: ARA)

Daily Technical Chart for (NYSE: ARA)


Stay tuned for daily updates and more on (NYSE: ARA)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: ARA)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ARA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ARA and does not buy, sell, or trade any shares of ARA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/